You are here
International MedTech Industry a Major Focus at AdvaMed 2013
WASHINGTON, D.C. – AdvaMed 2013: The MedTech Conference begins today at the Walter E. Washington Convention Center in Washington, D.C. with a major emphasis on the opportunities and challenges facing the medical technology industry in an increasingly global marketplace. International-themed programming includes networking events, perspectives on regulatory developments in Asia, Saudi Arabia and the European Union, suggestions on accessing private capital outside of the U.S., and several sessions focusing on key MedTech markets including Brazil, Japan and Germany.
Kicking off the popular CEOs Unplugged series, top executives from Sorin Group, CVRx and Johnson & Johnson will offer a “CEOs’ Take on Regulatory Developments in the European Union.” Centered on revised regulations for medical devices and in vitro diagnostics proposed by the European Commission last fall, the CEO panel will dive into the ongoing debate and discuss the implications for marketing devices in the EU and global supply chain strategy.
Many of the conference panels will examine the business impact of medical technology on a global scale, including a Wednesday session entitled “Catching the Financial Waves Abroad: Accessing Private Sources of Capital in Non-U.S. Markets.” Focused on strategies to raise private funds throughout Europe, Asia and other parts of the world, the panel session will feature seasoned investors from NBGI Ventures, Vivo Ventures LLC, and Ally Bridge Group/Themes Investment Management.
Other panel sessions with an international focus include:
- “Expanding Brazil’s Role in the Global Medical Technology Industry,” featuring speakers from 3M, ABIMO – Brazilian Medical Devices Manufacturers Association – and the Director of ANVISA, the Brazilian Health Regulatory Agency;
- “Changing Regulatory Requirements and Harmonization Efforts in Asia: How Will They Impact Your Company,” featuring executives from Brandwood Biomedical, the Pharmaceuticals and Medical Devices Agency of Japan, and the Saudi Food & Drug Authority; and
- “The Physician Payment Sunshine Acts - From America to France and Other Jurisdictions – New/Expanded Transparency and Compliance Requirements,” featuring industry leaders from, 3M, Boston Scientific Corporation, Covidien, LCH, Medtronic, and Willkie Farr & Gallagher LL
Delegations comprised of emerging and established MedTech markets from Australia, Canada, Finland, France, Macedonia, New Zealand and the UK will attend and participate in AdvaMed 2013. A networking lunch featuring remarks from thought leaders on the global MedTech marketplace is being held today for all international organizations and companies, and the Entrepreneurship Boot Camp will explore the keys to successful U.S. market entry for small companies from outside the U.S.
For a full conference agenda, visit http://www.advamed2013.com.
About AdvaMed 2013: The MedTech Conference
AdvaMed 2013: The MedTech Conference is the leading gathering in North America of global MedTech executives with regulatory, reimbursement, business development, legal, IP, marketing, quality, compliance, and other key responsibilities. Along with industry leaders, the conference attracts business development professionals, investors, policy-makers, members of the media, legal experts, consultants, distributors, and other important stakeholders will attend this international conference.
More than 2,000 attendees will network, conduct business, gain access to capital and share insights in Washington, D.C. from September 23-25. The conference also features world-class plenary speakers, networking and business development opportunities. Visit http://advamed2013.com, follow @AdvaMed2013 on Twitter, or join the AdvaMed 2013 LinkedIn group to learn more.
# # #
Lisa Fels (AdvaMed 2013) 973-886-1917 or email@example.com